PAC0012PR: Pancreatic Ductal Adenocarcinoma

TRACE-PDTX platform

Sex Male
Age at Time of Collection 83
Race / Ethnicity / Not Specified
Patient Tumor
Histology Pancreatic Ductal Adenocarcinoma
Primary Tissue pancreas
Collection Site pancreas
Tumor Type Primary
Grade Not specified
Stage cT4N1M1 ( Classification: TNM staging system)
PDX model Engraftment
Host Strain Name Site Type Material Material Status Passage
NMRI nude interscapular fat pad heterotopic tissue biopsy fresh 0, 1, 2, 3
Model Quality Control
Technique Description Passage
Histology high concordance between xenograft and patient tumour 0,1,2,3
Fingerprinting high concordance between xenograft and patient tumour 0,1,2,3
Collection (Current Model)
Age 83
Diagnosis Pancreatic Ductal Adenocarcinoma
Type Primary
PDX Mouse PAC0012PR
Collection Site pancreas
Sex Male
Race / Ethnicity Not specified / Not Specified
Date Regimen Started Regimen Dose Best Response Duration (Months)
Sep 13 Gemcitabine Gemcitabine 1000 mg/m2 weekly (7 of 8 wks in cycle 1, then 3 of 4 wks in subsequent cycles) Progressive Disease 2.0

Sample ID:     Histology:     Tumor Type: Engrafted Tumor     Passage:     Platform: